New Review in Clinical and Experimental Metastasis

1 minute read

Published:

We are pleased to announce that review article Mechanisms of Breast Cancer Dormancy in Bone Metastasis has been accepted for publication in Clinical and Experimental Metastasis. The review brings together current knowledge on how disseminated breast cancer cells survive in a dormant state within the bone microenvironment and the mechanisms that eventually trigger their reactivation and metastatic growth.

Bone metastasis remains one of the most significant clinical challenges in breast cancer, with dormant tumour cells capable of evading treatment and persisting for years or even decades before recurring. This review examines the complex interactions between tumour cells and the bone microenvironment that regulate dormancy, including the roles of osteoblasts, osteoclasts, immune cells, hypoxia, extracellular signalling pathways and metabolic adaptation. It also discusses the biological mechanisms that drive tumour reawakening and metastatic progression.

In addition to summarising recent advances in our understanding of tumour dormancy, the review provides a comprehensive overview of the experimental models and emerging technologies used to study this process. These include three-dimensional culture systems, patient-derived models, intravital imaging, spatial transcriptomics and computational approaches, highlighting both the opportunities and the challenges in developing more effective therapies to prevent metastatic relapse.

This review provides an accessible overview of a rapidly evolving field and identifies important directions for future research aimed at preventing breast cancer recurrence and improving long-term patient outcomes.